Literature DB >> 30348606

Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.

Qiang Zhang1, Zhengmin Wang2, Xianying Meng2, Quan-Yang Duh3, Guang Chen4.   

Abstract

BACKGROUND: Presence of lymph node metastases increases the risk of recurrence, but prophylactic central neck node dissection for patients with micropapillary thyroid cancer (mPTC) is controversial. We aim to find the clinical predictors of central lymph node metastases (CLNM) in patients with cN0 mPTC.
METHODS: We retrospectively reviewed the clinicopathological and molecular genetic characteristics of 1304 patients with cN0 mPTC operated at the First Hospital of Jilin University between January 1, 2013 and May 31, 2016, all underwent thyroid lobectomy or total thyroidectomy with unilateral or bilateral prophylactic central neck dissection. Univariate and multivariate analysis were used to identify the predictors of CLNM.
RESULTS: 30.7% of cN0 mPTC patients had CLNM. Univariate analysis found CLNM to be associated with younger age (≤45), male gender, larger tumor (>0.5 cm), multifocality, bilaterality, capsular invasion, lymphovascular invasion and extrathyroidal infiltration, but not associated with BRAF mutation, tumor location, preoperative TSH and anti-thyroglobulin antibody level. Multivariate logistic regression showed age ≤45 years (p < 0.001, OR = 2.05), male gender (p < 0.001, OR = 1.94), tumor size >0.5 cm (p < 0.001, OR = 1.87), bilaterality (p = 0.003, OR = 1.86) and capsular invasion (p = 0.013, OR = 1.49) to be independent predictors for CLNM in cN0 mPTC patients.
CONCLUSIONS: Prophylactic central neck dissection has higher yield for cN0 mPTC patients with age ≤45 years, male gender, tumor size>0.5 cm, bilaterality and capsular invasion. BRAF mutation is not a predictor for CLNM in cN0 mPTC patients.
Copyright © 2018. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  BRAF; Central lymph node metastases; Papillary thyroid microcarcinoma; cN0; mPTC

Mesh:

Substances:

Year:  2018        PMID: 30348606     DOI: 10.1016/j.asjsur.2018.08.013

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  12 in total

1.  Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaodong He
Journal:  Gland Surg       Date:  2020-06

2.  The relationship between central lymph node metastasis and the distance from tumor to thyroid capsule in papillary thyroid microcarcinoma without capsule invasion.

Authors:  Mengting Zhu; Weihui Zheng; Yangfeng Xiang; Jialei Gu; Kejing Wang; Jinbiao Shang
Journal:  Gland Surg       Date:  2020-06

3.  Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas.

Authors:  Yanfang Wang; Fang Nie; Guojuan Wang; Ting Liu; Tiantian Dong; Yamin Sun
Journal:  Cancer Manag Res       Date:  2021-04-19       Impact factor: 3.989

4.  The Extent of Therapeutic Central Compartment Neck Dissection in Unilateral cT1N1a or cT2N1a Papillary Thyroid Carcinoma.

Authors:  Nan Liu; Yupeng Yang; Bo Chen; Luchuan Li; Qingdong Zeng; Lei Sheng; Bin Zhang; Weili Liang; Bin Lv
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

5.  Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015.

Authors:  Agnieszka Czarniecka; Marcin Zeman; Grzegorz Wozniak; Adam Maciejewski; Ewa Stobiecka; Ewa Chmielik; Malgorzata Oczko-Wojciechowska; Jolanta Krajewska; Daria Handkiewicz-Junak; Barbara Jarzab
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-06       Impact factor: 5.555

6.  Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.

Authors:  Xingzhu Wen; Qianmei Jin; Xiaoxia Cen; Ming Qiu; Zhihong Wu
Journal:  World J Surg Oncol       Date:  2022-04-01       Impact factor: 2.754

7.  Integrated bioinformatics analysis to screen hub genes in the lymph node metastasis of thyroid cancer.

Authors:  Si Lu; Rongjie Zhao; Jie Shen; Yu Zhang; Jingjing Shi; Chenke Xu; Jiali Chen; Renbin Lin; Weidong Han; Dingcun Luo
Journal:  Oncol Lett       Date:  2019-12-06       Impact factor: 2.967

8.  Risk Factors of Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma and the Value of Sentinel Lymph Node Biopsy.

Authors:  Jing Zhao; Ye Zhao; Yuwei Ling; Hua Kang
Journal:  Front Surg       Date:  2021-06-16

9.  Diagnostic Efficacy of Ultrasound, Cytology, and BRAFV600E Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.

Authors:  Jing Du; Ruijun Han; Cui Chen; Xiaowei Ma; Yuling Shen; Jun Chen; Fenghua Li
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

10.  Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension.

Authors:  Jin-Duo Shou; Fei-Bo Li; Liu-Hong Shi; Liang Zhou; Lei Xie; Jian-Biao Wang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.